Rxo (RXO) Non-Current Deferred Tax Liability (2021 - 2026)

Rxo (RXO) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $36.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 53.25% year-over-year to $36.0 million; the trailing twelve-month figure through Mar 2026 stood at $36.0 million (down 53.25% YoY), and the FY2025 full-year result was $51.0 million, down 66.67% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $36.0 million, down from $51.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $153.0 million in Q4 2024 and bottomed at $1.0 million in Q1 2024.
• The 5-year median for Non-Current Deferred Tax Liability is $43.5 million (2022), against an average of $50.3 million.
• The widest annual swing landed in 2024, when Non-Current Deferred Tax Liability sank 93.75%; it then soared 7600.0% in 2025.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $43.0 million in 2022, then tumbled by 83.72% to $7.0 million in 2023, then soared by 2085.71% to $153.0 million in 2024, then sank by 66.67% to $51.0 million in 2025, then declined by 29.41% to $36.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $36.0 million (Q1 2026), $51.0 million (Q4 2025), and $54.0 million (Q3 2025), per Business Quant data.

Peer Comparison